STAT's Drug Story Podcast: Ambien, Ozempic, EpiPen
SkimNews Take
By focusing on the narratives and broader societal impact of drugs, the podcast may inadvertently reinforce a consumer-centric view of medicine, potentially obscuring the complex, often opaque, R&D and regulatory processes that precede public availability.
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Thomas Goetz hosts the new 'Drug Story' podcast, exploring each drug’s cultural, economic and medical impact.
- First Opinion formats each episode in three acts, borrowing the structure from 'This American Life'.
- STAT distributes the podcast on Apple Podcasts, Spotify, and other platforms, and sends a weekly newsletter every Sunday.
- Ambien is one of the drugs highlighted, illustrating how a sleep aid can shape society and policy.
Why it matters: Not enough in the article to say why this matters.
Ask SkimNews
